Market research
NDRAW ENDRA Life Sciences Inc. Warrants
NASDAQ USD Other
Latest close
—
—
Loading market data…
Test a moving-average rule with historical data.
- Market cap
- Not available
- P/E ratio
- Not available
- Analyst target
- Not available
- Dividend yield
- 0.0%
- Beta
- Not available
Community
Investor discussion
1 comment
Sign in to join the NDRAW discussion.
5 years, 4 months ago
ENDRA Life Sciences Inc. Warrants is currently in a long term uptrend where the price is trading 24.8% above its 200 day moving average.
From a valuation standpoint, the stock is 100.0% cheaper than other stocks from the Other sector with a price to sales ratio of 0.0.
Its net income has increased by 99.9% to $-12K since the same quarter in the previous year.
Finally, its free cash flow fell by 118.3% to $-4M since the same quarter in the previous year.
Based on the above factors, ENDRA Life Sciences Inc. Warrants gets an overall score of 3/5.